-+ 0.00%
-+ 0.00%
-+ 0.00%

Upstream Bio Q1 EPS $(0.51) Misses $(0.49) Estimate, Sales $566.00K Beat $327.50K Estimate

Benzinga·05/06/2025 13:28:21
Listen to the news
Upstream Bio (NASDAQ:UPB) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.49) by 4.08 percent. The company reported quarterly sales of $566.00 thousand which beat the analyst consensus estimate of $327.50 thousand by 72.82 percent.